Prevention of N-methyl-D-aspartate (NMDA) Antagonist-induced Psychosis in Kids

Clinical trial NCT00205712 · COMPLETED

Trial details

NCT number: NCT00205712
Sponsor: Washington University School of Medicine
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Psychoses, Substance-Induced

Start date: 2003-02-01
Primary completion: 2007-10-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.